Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer

Clinical Cancer Research

Volumn 3, Issue 12 I, 1997, Pages 2485-2492

  Giatromanolaki, Alexandra ^a,c   Koukourakis, Michael I ^a,c   Theodossiou, Dimitrios ^a   Barbatis, Kalypso ^b   O'Byrne, Ken ^c   Harris, Adrian L ^c   Gatter, Kevin C ^c  

^a UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

^b RED CROSS HOSPITAL   (Greece)

^c OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; CD31 ANTIGEN;

ANGIOGENESIS; ARTICLE; CANCER GRADING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG BIOPSY; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ADENOCARCINOMA; ANTIGENS, CD; ANTIGENS, CD31; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FACTOR VIII; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; LYMPHOCYTES, TUMOR-INFILTRATING; MICROCIRCULATION; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; OBSERVER VARIATION; PROBABILITY; PROGNOSIS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0031409283     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Gasparini, G. Angiogenesis research up to 1996. A commentary on the state of art and suggestions for future studies. Eur. J. Cancer, 14: 2379-2385, 1996.
2. Craft, P. S., and Harris, A. L. Clinical prognostic significance of tumor angiogenesis. Ann. Oncol., 5: 305-311, 1994.
3. Parums, D. V., Cordell, J. L., Micklem, K., Heryet, A. R., Gatter, K. C., and Mason, D. Y. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J. Clin. Pathol., 43: 752-757, 1990.
4. Schlingeman, R. O., Rietveld, F. J. R., de Wall, R. M. W., et al. Leucocyte antigen CD34 is expressed by a subset of endothelial cells and on endothelial albuminal microprocesses in the tumor stroma. Lab. Invest., 62: 690-696, 1990.
5. Alles, J. I., and Bosslet, K. Immunohistochemical and immunochemical characterization of a new endothelial cell specific antigen. J. Histochem. Cytochem., 34: 209-216, 1986.
6. Macchiarini, P., Fontanini, G., Hardin, M. J., Squartini, F., and Angeletti, C. A. Relation of neovascularization to metastasis of non-small cell lung cancer. Lancet, 340: 145-146, 1992.
7. Yamazaki, K., Abe, S., Yakekawa, H., Sukoh, N., Watanabe, N., Ogura, S., Nakajima, I., Isobe, H., Inoue, K., and Kawakami, Y. Tumor angiogenesis in human lung adenocarcinoma. Cancer (Phila.), 74: 2245-2250, 1994.
8. Fontanini, G., Bigini, D., Vignati, S., Basolo, F., Mussi, A., Lucchi, M., Chine, S., Angeletti, C. A., Harris, A. L., and Bevilacqua, G. Microvessel count predicts metastatic disease and survival in non-small cell Ing cancer. J. Pathol., 177: 57-63, 1995.
9. Yan, A., Yng, P. C., Yu, C. J., et al. Tumor angiogenesis correlates with histologic type and metastasis in non-small cell lung cancer. Am. J. Respir. Crit. Care Med., 152: 2157-2162, 1995.
10. Harpole, D. H., Jr., Richards, W. G., Herndon, J. E., II, and Sugarbaker, L. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer. Ann. Thorac. Surg., 61: 1470-1476, 1996.
11. Giatromanolaki, A., Koukourakis, M., O'Byrne, K., Fox, S., Whitehouse, R., Talbot, D., Harris, A. L., and Gatter, K. C. Prognostic value of angiogenesis in operable non-small cell lung cancer. J. Pathol., 179: 80-88, 1996.
12. Fontanini, G., Vignati, S., Bigini, D., Lucchi, M., Mussi, A., Basolo, F., Angeletti, C. A., and Bevilacqua, G. Neo-angiogenesis: a putative marker of malignancy in non-small cell lung cancer (NSCLC) development. Int. J. Cancer, 67: 615-619, 1996.
13. Vermeulen, P. B., Gasparini, G., Fox, S. B., Toi, M., Martin, L., McCulloch, P., Pezzella, F., Viale, G., Weidner, N., Harris, A. L., and Dirix, L. Y. Quantification of angiogenesis in solid tumors: an international consensus on the methodology and criteria of evaluation. Eur. J. Cancer, 14: 2474-2484, 1996.
14. Mountain, C. F. A new international staging system for lung cancer. Chest, 89 (Suppl): 225-233, 1986.
15. Fox, S. B., Moghaddam, A., Westwood, M., Turley, H., Bicknell, R., Gatter, K. C., and Harris, A. L. Platelet derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues an immunohistochemical study. J. Pathol., 176: 183-190, 1995.
16. Toi, M., Hoshina, S., Taniguchi, T., Yamamoto, Y., Ishitsuka, H., and Tominaga, T. Expression of platelet-derived endothelial cell growth factor/thymidine phospshorylase in human breast cancer. Int. J. Cancer, 64: 79-82, 1995.
17. Takebayashi, Y., Miyadera, K., Akiyama, S., Hokita, S., Yamada, K., Akiba, S., Sumizawa, T., and Aikou, T. Expression of thymidine phosphorylase in human gastric carcinoma. Jpn. J. Cancer Res., 87: 288-295, 1996.
18. Takahashi, Y., Bucana, C. D., Liu, W., Yoneda, J., Kitadai, Y., Cleary, K. R., and Ellis, L. M. Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. J. Natl. Cancer Inst., 88: 1146-1151, 1996.
19. Koukourakis, M. I., Giatromanolaki, A., O'Byrae, K., Comley, M., Whitehouse, R., Talbot, D. C., Gatter, K. C., and Harris, A. L. Platelet-derived endothelial cell growth factor expression correlates with tumor angiogenesis and prognosis in non-small cell lung cancer. Br. J. Cancer 4: 477-481, 1997.
20. Giatromanolaki, A., Koukourakis, M., Comley, M., Kaklamanis, L., Turley, H., O'Byrne, K., Harris, A. L., and Gatter, K. C. Platelet-derived endothelial cell growth factor (thymidine phosphorylase) expression in lung cancer. J. Pathol., 181: 196-199, 1997.
21. Giatromanolaki, A., Koukourakis, M., O'Byrne, K., Whitehouse, R., Gatter, K. C., and Harris, A. L. Lymphocytic macrophage infiltration and tumor neo-angiogenesis in non-small cell lung cancer. In: G. Antypas (ed.), 2nd International Lung Cancer Congress, pp. 107-111. Bologna: Monduzzi Editore, 1996.
22. Dvorak, H. F., Nagy, J. A., Dvorak, J. T., and Dvorak, A. M. Identification and characterisation of blood vessels of solid tumors that are leaky to circulating macromolecules. Am. J. Pathol., 133: 95-109, 1988.
23. Murray, J. C., Smith, K. A., and Kauk, S. Vascular markers for murine tumors. Radiother. Oncol., 16: 221-234, 1989.
24. Denekamp, J. Vascular attack as a therapeutic strategy for cancer. Cancer Metastasis Rev., 9: 267-282, 1990.
25. Vermeulen, P. B., Verhoeven, D., Fierens, H., Hubens, G., Goovaerts, G., Van Marck, E., De Bruijn, E. A., Van Oosterom, A. T., and Dirix, L. Y. Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study. Br. J. Cancer., 71: 340-343, 1995.
26. Albelda, S. M., Smith, C. W., and Ward, P. A. Adhesion molecules and inflammatory injury. FASEB J., 8: 504-512, 1995.
27. Zocchi, M. R., Ferrero, E., Leone, B. E., Rovere, P., Bianchi, E., Toninelli, E., and Pardi, R. CD31/PECAM-1 driven chemokine-independent transmigration of human T-lymphocytes. Eur. J. Immunol., 26: 759-767, 1996.
28. Sankar, S., Mahooti, Brooks, N., Bensen, L., McCarthy, T. L., Centrella, M., and Madri, J. A. Modulation of transforming growth factor β receptor levels on microvascular endothelial cells during in vitro angiogenesis. J. Clin. Invest., 97: 1436-1446, 1996.
29. Akaogi, K., Okabe, Y., Sato, J., Nagashima, Y., Yasumitsu, H., Sugahara, K., and Miyazaki, K. Specific accumulation of tumor-derived adhesion factor in tumor blood vessels and in capillary tube-like structures of cultured vascular endothelial cells. Proc. Natl. Acad. Sci. USA. 93: 8384-8389, 1996.
30. Maheshwari, R. K., Srikantan, V., Bhartiya, D., Kleinman, H. K., and Grant, D. S. Differential effects of interferon γ and α on in vitro model of angiogenesis. J. Cell. Physiol., 146: 164-169, 1991.
31. O'Brien, T. S., Fox, S. B., Dickinson, A. J., Turley, H., Westwood, M., Moghaddam, A., Gatter, K. C., Bicknell, R., and Harris, A. L. Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res., 56: 4799-4804, 1996.
32. Rak, J., Filmus, J., and Kerbel, R. S. Reciprocal paracrine interactions between tumor cells and endothelial cells: the "angiogenesis progression" hypothesis. Eur. J. Cancer, 14: 1438-2450, 1996.
33. Fox, S. B., Leek, R. D., Weekes, M. P., Whitehouse, R. M., Gatter, K. C., and Harris, A. L. Quantitation and prognostic value of breast cancer angiogenesis. Comparison of microvessel density, chalkley count, and computer image analysis. J. Pathol., 177: 275-283, 1995.
34. Sotos, G. A., Grogan, L., and Allegra, C. J. Preclinical and clinical aspects of biomodulation of 5-fluorouracil. Cancer Treat. Rev., 20: 11-49, 1994.
35. Moghaddam, A., Zhang, H. T., Fan, T. P. D., Hu, D. E., Lees, V. C., Turley, H., Fox, S. B., Gatter, K. C., Harris, A. L., and Bicknell, R. Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc. Natl. Acad. Sci. USA, 92: 998-1002, 1995.
36. Demeure, C. E., Byun, D. G., Yang, L. P., Vezzio, N., and Delespesse, G. CD31 (PECAM-is a differentiation antigen lost during human CD4 T-cell maturation into Th1 or Th2 effector cells. Immunology, 88: 110-115, 1996.
37. Piali, L., Hammel, P., Uherek, C., Bachmann, F., Gisler, R. H., Dunon, D., Imfof, B. A. CD31/PECAM-1 is a ligand for a v β 3 integrin involved in adhesion of leukocytes to endothelium. J. Cell. Biol., 130: 451-460, 1995.
38. Pupa, S. M., Bufalino, R., Invernizzi, A. M., Andreola, S., Rilke, F., Lombardi, L., Colnaghi, M. I., and Menard, S. Macrophage infiltrated and prognosis in c-erbB-2 overexpressing breast carcinomas. J. Clin. Oncol., 14: 85-94, 1996.
39. Anastassiou, G., Duensing, S., Steinhoff, G., Zorn, U., Grosse, J., Dallmann, I., Kirchner, H., Ganser, A., and Atzpodien, J. Platelet endothelial cell adhesion molecule-1 (PECAM-1): a potential prognostic marker involved in leukocyte infiltration of renal cell carcinoma. Oncology, 53: 127-132, 1996.